Hyperphosphorylation of tau is mediated by ERK activation during anticancer drug-induced apoptosis in neuroblastoma cells.
about
RETRACTED: TGFβ1 activates c-Jun and Erk1 via αVβ6 integrinZonisamide Enhances Neurite Elongation of Primary Motor Neurons and Facilitates Peripheral Nerve Regeneration In Vitro and in a Mouse ModelAndrographolide induces apoptosis of C6 glioma cells via the ERK-p53-caspase 7-PARP pathway.Doxorubicin attenuates serotonin-induced long-term synaptic facilitation by phosphorylation of p38 mitogen-activated protein kinase.Phosphorylation of p90RSK is associated with increased response to neoadjuvant chemotherapy in ER-positive breast cancer.N-(4-hydroxyphenyl)retinamide-induced apoptosis triggered by reactive oxygen species is mediated by activation of MAPKs in head and neck squamous carcinoma cellsSynaptic therapy in Alzheimer's disease: a CREB-centric approach.Calpain mediates calcium-induced activation of the erk1,2 MAPK pathway and cytoskeletal phosphorylation in neurons: relevance to Alzheimer's diseaseHyperphosphorylated tau in young and middle-aged subjects.NMNAT suppresses tau-induced neurodegeneration by promoting clearance of hyperphosphorylated tau oligomers in a Drosophila model of tauopathy.Amyloid precursor protein and presenilin involvement in cell signaling.H2S-induced pancreatic acinar cell apoptosis is mediated via JNK and p38 MAP kinase.Knockdown of TRPM8 suppresses cancer malignancy and enhances epirubicin-induced apoptosis in human osteosarcoma cells.Neurodegeneration in Alzheimer disease: role of amyloid precursor protein and presenilin 1 intracellular signaling.Luteolin reduces zinc-induced tau phosphorylation at Ser262/356 in an ROS-dependent manner in SH-SY5Y cells.Blocking of ERK1 and ERK2 sensitizes human mesothelioma cells to doxorubicin.Amyloid precursor protein modulates ERK-1 and -2 signaling.Involvement of ERK1/2 and p38 MAP kinase in doxorubicin-induced uPA expression in human RC-K8 lymphoma and NCI-H69 small cell lung carcinoma cells.TRAIL activates a caspase 9/7-dependent pathway in caspase 8/10-defective SK-N-SH neuroblastoma cells with two functional end points: induction of apoptosis and PGE2 release.Opposite long-term regulation of c-Myc and p27Kip1 through overactivation of Raf-1 and the MEK/ERK module in proliferating human choroidal melanoma cells.Tau and caspase 3 as targets for neuroprotection.Identification of a mouse cytoskeleton-associated protein, CKAP2, with microtubule-stabilizing properties.Rapid tau aggregation and delayed hippocampal neuronal death induced by persistent thrombin signaling.Growth factor receptor-bound protein 2 interaction with the tyrosine-phosphorylated tail of amyloid beta precursor protein is mediated by its Src homology 2 domain.Doxorubicin induces EGF receptor-dependent downregulation of gap junctional intercellular communication in rat liver epithelial cells.COX-2 metabolic products, the prostaglandin I2 and F2α, mediate the effects of TNF-α and Zn2+ in stimulating the phosphorylation of Tau.MAP kinases regulate unfertilized egg apoptosis and fertilization suppresses death via Ca2+ signaling.Paclitaxel targets mitochondria upstream of caspase activation in intact human neuroblastoma cells.Variable apoptotic response of NSCLC cells to inhibition of the MEK/ERK pathway by small molecules or dominant negative mutants.Doxorubicin induces an extensive transcriptional and metabolic rewiring in yeast cells
P2860
Q24805249-6919B893-B368-402D-9A70-76F9BCA5939EQ28550982-F3FBAF61-C5D1-43E2-ACBD-E7F022677CBEQ34069873-E67E0D8B-E68B-4C4C-9948-8FC8DACDB8B5Q34268924-163F8AED-2B35-4374-B67A-D3985F991949Q34502227-1DA4B8F3-84A8-4BDE-ACD1-61678B66CEF1Q34594976-9D26E18F-E6C0-42E7-BB41-FFAFCABBA537Q35064948-CFDACD65-38F3-4309-90BD-75AD3D870E04Q35103074-BE8D675D-8E77-4668-80C2-5792A7A8A0D8Q35644063-9835A2B9-5F5C-4922-84AE-E75E2421BE28Q35747174-FB50F346-221B-4DF2-8DA5-73B079098A20Q36863026-408E5971-0FBC-4A0E-9042-05DFBDDE8939Q37398303-A40CBEF5-854B-4F0D-BB21-B1ECE840CE31Q37428766-6458F3C7-BC93-4B82-87F1-4B9AF66CB740Q38002023-3E1DAEA8-15F2-4C4E-BCD8-71CED3607AECQ39359828-C5487708-9780-4045-81FD-DB984BDA7FCEQ39620039-9CC82B1D-B530-4A28-9293-57F53A3344F8Q40154388-D9509D54-9C93-4BC4-9448-5C635309103CQ40489044-9246F054-7268-47E6-A546-F7A93A6A75C4Q40608394-D366D55A-1373-4ED5-B7EE-24B99EE3F330Q40610753-F530A899-F3F4-4E2C-AE41-E59E14795463Q42151546-AFB20CE2-37CA-4CE7-8361-ADAB5568CF64Q42824227-3E14D7C9-659B-45B9-9ED0-57F5C328007DQ44488090-38F2B336-5AAB-4783-9D37-4AD986857B84Q44822089-53AD4732-60C9-4C79-929E-6A373E107CC7Q46447814-B7904CD1-ADD5-49C6-91E5-A2A7414EFF4FQ47160386-DFB9B717-21A1-4BE9-B93E-4E019EA78FBDQ50682071-F387C30A-25E8-45B6-9C39-F3C2E067CE94Q51695744-E45C4075-6EEB-4ABB-84F9-A785F87427AAQ53961769-AC7B32C2-1244-439D-9B47-304168CE3488Q58747454-36C386A7-1B77-4BF4-94D2-C5C4C4F8D070
P2860
Hyperphosphorylation of tau is mediated by ERK activation during anticancer drug-induced apoptosis in neuroblastoma cells.
description
2001 nî lūn-bûn
@nan
2001年の論文
@ja
2001年学术文章
@wuu
2001年学术文章
@zh
2001年学术文章
@zh-cn
2001年学术文章
@zh-hans
2001年学术文章
@zh-my
2001年学术文章
@zh-sg
2001年學術文章
@yue
2001年學術文章
@zh-hant
name
Hyperphosphorylation of tau is ...... ptosis in neuroblastoma cells.
@en
Hyperphosphorylation of tau is ...... ptosis in neuroblastoma cells.
@nl
type
label
Hyperphosphorylation of tau is ...... ptosis in neuroblastoma cells.
@en
Hyperphosphorylation of tau is ...... ptosis in neuroblastoma cells.
@nl
prefLabel
Hyperphosphorylation of tau is ...... ptosis in neuroblastoma cells.
@en
Hyperphosphorylation of tau is ...... ptosis in neuroblastoma cells.
@nl
P2093
P2860
P1476
Hyperphosphorylation of tau is ...... ptosis in neuroblastoma cells.
@en
P2093
P2860
P304
P356
10.1002/1097-4547(20010201)63:3<257::AID-JNR1019>3.0.CO;2-T
P577
2001-02-01T00:00:00Z